News about Market

Budget 2022: Many offerings for Pharma and Healthcare sector

Budget 2022: Many offerings for Pharma and Healthcare sector

India proposed doubling healthcare spending in an annual budget unveiled on Monday and lifted caps on foreigners investing in its vast insurance market to help revive an economy that suffered its deepest recorded slump as a result of the pandemic

Market | 01/02/2022 | By Darshana 443

JB Chemicals and Pharmaceuticals to acquire brands from Sanzyme

JB Chemicals and Pharmaceuticals to acquire brands from Sanzyme

JB Chemicals and Pharmaceuticals yesterday announced that it will acquire brands for the India market from Sanzyme, a player in the probiotics and reproductive health segment in the country. The transaction is valued at approximately Rs 628 crores, and is expected to be completed in the next two weeks subject to customary closing formalities

Market | 27/01/2022 | By Darshana 501

HealYos and Emoha join hands to provide home healthcare facilities in western India

HealYos and Emoha join hands to provide home healthcare facilities in western India

The Corona pandemic has jolted the healthcare system. Healthcare should be accessible to everyone and home healthcare bridges that gap. In its bid to provide robust home-based healthcare services in western India, HealYos Home Healthcare and Emoha Elder Care Services have joined hands

Market | 05/01/2022 | By Darshana 333

Apollo Hospitals may garner 14% market share in e-pharmacy business in next five years: Motilal Oswal report

Apollo Hospitals may garner 14% market share in e-pharmacy business in next five years: Motilal Oswal report

Healthcare major Apollo Hospitals Enterprises Ltd (AHEL) is expected to see its e-pharmacy business to gain around 14 per cent market share over the next five years, driven by the omni-channel model it is currently working on, according to a latest report from Motilal Oswal Financial Services Ltd (MOFSL)

Market | 24/12/2021 | By Darshana 350

Encube Ethicals to acquire Soframycin for India and Sri Lanka markets from Sanofi

Encube Ethicals to acquire Soframycin for India and Sri Lanka markets from Sanofi

Encube Ethicals has agreed to enter into definitive agreements with Sanofi group and its affiliates, including Sanofi India for acquiring some of its brands ? Soframycin, along with other legacy-associated brands Sofradex, Sofracort, Soframycin-Tulle for India and Sri Lanka markets, a statement from Encube notified

Market | 27/11/2021 | By Darshana 405

Jubilant Pharmova Q2 net profit stood at Rs.143 crore

Jubilant Pharmova Q2 net profit stood at Rs.143 crore

The company's radiopharma business witnessed improvement in sales YoY, however pace of recovery during the quarter was affected by increase in Covid-19 cases in the US, while CMO business revenue grew YoY based on continued strong demand from customers as well as due to Covid related deals

Market | 24/10/2021 | By Darshana 249

Doceree introduces opti-channel marketing for pharma sector in India

Doceree introduces opti-channel marketing for pharma sector in India

Doceree, the first global network of physician-only platforms for programmatic messaging, launched in India opti-channel marketing for the pharmaceutical sector, in its attempt to accelerate adoption of digital mediums in an industry which is relatively slow in embracing innovative digital technologies

Market | 28/09/2021 | By Darshana 301

Indian API, CRAMS sectors to outperform other countries during 2021-26: research report

Indian API, CRAMS sectors to outperform other countries during 2021-26: research report

The Indian active pharmaceutical ingredients (API) sector is expected to outperform other countries with an estimated Compound Annual Growth Rate (CAGR) of 9.6 per cent over the calendar year 2021-26, while complex APIs would see a faster growth owing to the focus on complex formulations and others

Market | 13/09/2021 | By Darshana 348

Deal value in pharma industry decreases by 67.2 per cent in August: Globalata

Deal value in pharma industry decreases by 67.2 per cent in August: Globalata

The latest GlobalData report has revealed that the pharmaceutical industry reported 56 deals worth $11.7 billion last month as compared to the last 12-month average (August 2020 to July 2021) of 104 deals worth $28.9 billion

Market | 08/09/2021 | By Darshana 288

RIL arm acquires stake in Strand Life Sciences

RIL arm acquires stake in Strand Life Sciences

Reliance Strategic Business Ventures Limited, a wholly owned subsidiary of Reliance Industries Limited has acquired stake in Strand Life Sciences for a cash consideration of Rs. 393 crore

Market | 04/09/2021 | By Darshana 299

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members